Nanoco Group plc is listed on the main market of the London Stock Exchange. We are the market leader in the research, development, licensing and manufacture of heavy-metal-free quantum dots, called CFQD® quantum dots, for use in various commercial applications.
We are a platform based technology company focused on bringing our technology to market for our partners and customers through innovation and research. The Group’s core technologies are the ability to scale up cost-effective production of high performance cadmium-free quantum dots and applications containing those CFQD® quantum dots.
Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a manufacturing facility in Runcorn, UK. We have a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition. Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.
Why invest in Nanoco
Significant increase in billings
(2018: £6.5 million)
Revenue more than doubled to
(2018: £3.3 million)
Loss after tax
(2018: £6.0 million)
of savings in FY20
contract liability by US Customer
as at 31 July 2019
Dr Christopher Richards
The successful delivery of a number of milestones and the new Runcorn production facility for our US Customer was a source of great pride for the whole Nanoco team and has driven the strongest financial results in the Group’s history. For the year to 31 July 2019, revenue more than doubled for the second year in a row to £7.1 million (2018: £3.3 million), our adjusted EBITDA loss was cut 38% to £3.8 million (2018: £6.2 million) and the second half saw the business generate a small cash surplus.
Loss after tax
Nanoco Group Company Research
Edison Group is an investment research, investor relations and consulting firm with offices in North America, Europe, and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
In this video CEO Dr Michael Edelman joins DirectorsTalk to discuss the funding of its lawsuit against Samsung. Michael provides us with some background to the lawsuit, insights into the funder, the due diligence period,...